The global dry eye syndrome treatment market accounted for USD 3.42 billion in 2016 growing at a CAGR of 6.9% during the forecast period of 2017 to 2024.
Dry eye syndrome treatment research report 2019 is a comprehensive, professional report delivering market research data that is relevant for new market entrants or established players. The research study covers…
DCGI canceled the license for Diclofenac injection marketed by Novartis
With the raised concern by the Indian health ministry panel the license of Diclofenac injection sold by Novartis has been canceled by DCGI. The brand name of the Diclofenac painkiller…
